Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3Pain 2Neoplasm Metastasis 2Hematologic Neoplasms 2Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Supratentorial Neoplasms 1Pain, Intractable 1Nephrolithiasis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Liver Neoplasms 1Leukemia 1Leiomyoma 1Kidney Neoplasms 1Ileus 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1Advanced Malignant Neoplasm 1

Interventions

Bevacizumab 69atezolizumab 54lenvatinib 42durvalumab 42Nivolumab 38pembrolizumab 35tremelimumab 28Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 17Ipilimumab 15Sorafenib 14regorafenib 13cabozantinib 13Radiosurgery 13Radiotherapy 12apatinib 11Blood Specimen Collection 11Immunoglobulin G 10camrelizumab 9Immune Checkpoint Inhibitors 9Disulfides 9X-Rays 8Cyclophosphamide 8donafenib 7Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Morphine × 1 year × Clear all
NCT07207304 2025-10-03

Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes

Iuliu Hatieganu University of Medicine and Pharmacy

Phase NA Completed
153 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡